The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade

Patrizia Sini(Novartis (Switzerland)), Jeanette M. Wood(Novartis (Switzerland))
Clinical Cancer Research
June 15, 2005
Cited by 86


Related Papers

No related papers found

Powered by citation graph analysis